Skip to main content
Erschienen in: Current Dermatology Reports 3/2019

01.07.2019 | Wound Care (H Lev-Tov, Section Editor)

Clinic-Based Surgical Treatment for Hidradenitis Suppurativa

verfasst von: Kristen Fajgenbaum, Jonathan Bissette, Christopher Sayed

Erschienen in: Current Dermatology Reports | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

We provide an evidence-based review of current procedures and provide a practical guide to surgically treating hidradenitis suppurativa in the office setting.

Recent Findings

Outpatient procedural management of hidradenitis suppurativa may include incision and drainage, intralesional triamcinolone, deroofing, excision, and lasers that achieve follicular destruction. Managing recurrent lesions, scarring, and sinus tracts often requires deroofing or excision. Recurrence rates are likely similar between deroofing and excision by sharp or laser techniques, and high patient satisfaction is consistently reported. Recently published treatment guidelines support the use of a variety of procedures that can be approached in the office setting.

Summary

Optimizing treatment of hidradenitis suppurativa, a debilitating chronic condition, often requires a combination of procedural and medical interventions. The ability to offer a variety of surgical interventions based on patient preference in an office setting is an important asset for clinicians caring for hidradenitis suppurativa patients. In the future, research should focus on comparing the effectiveness and tolerability of these procedures in various settings.
Literatur
1.
Zurück zum Zitat Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA Dermatol. 2017;153(8):760–4.PubMedPubMedCentralCrossRef Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA Dermatol. 2017;153(8):760–4.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol. 1996;35(2 Pt 1):191–4.PubMedCrossRef Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol. 1996;35(2 Pt 1):191–4.PubMedCrossRef
3.
Zurück zum Zitat Matusiak L, Bieniek A, Szepietowski JC. Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol. 2010;90(3):264–8.PubMedCrossRef Matusiak L, Bieniek A, Szepietowski JC. Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol. 2010;90(3):264–8.PubMedCrossRef
4.
Zurück zum Zitat Matusiak L, Bieniek A, Szepietowski JC. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol. 2010;62(4):706–708, 708 e701.PubMedCrossRef Matusiak L, Bieniek A, Szepietowski JC. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol. 2010;62(4):706–708, 708 e701.PubMedCrossRef
5.
Zurück zum Zitat Alavi A, Farzanfar D, Lee RK, Almutairi D. The contribution of malodour in quality of life of patients with hidradenitis suppurativa. J Cutan Med Surg. 2018;22(2):166–74.PubMedCrossRef Alavi A, Farzanfar D, Lee RK, Almutairi D. The contribution of malodour in quality of life of patients with hidradenitis suppurativa. J Cutan Med Surg. 2018;22(2):166–74.PubMedCrossRef
6.
Zurück zum Zitat Alavi A, Farzanfar D, Rogalska T, Lowes MA, Chavoshi S. Quality of life and sexual health in patients with hidradenitis suppurativa. Int J Womens Dermatol. 2018;4(2):74–9.PubMedPubMedCentralCrossRef Alavi A, Farzanfar D, Rogalska T, Lowes MA, Chavoshi S. Quality of life and sexual health in patients with hidradenitis suppurativa. Int J Womens Dermatol. 2018;4(2):74–9.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Cuenca-Barrales C, Ruiz-Villaverde R, Molina-Leyva A. Sexual distress in patients with hidradenitis suppurativa: a cross-sectional study. J Clin Med. 2019;8(4):532. Cuenca-Barrales C, Ruiz-Villaverde R, Molina-Leyva A. Sexual distress in patients with hidradenitis suppurativa: a cross-sectional study. J Clin Med. 2019;8(4):532.
8.
Zurück zum Zitat Hurley H. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In: RRH R, editor. Dermatologic Surgery. New York: Marcel Dekker; 1989. p. 729–39. Hurley H. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In: RRH R, editor. Dermatologic Surgery. New York: Marcel Dekker; 1989. p. 729–39.
10.
Zurück zum Zitat •• Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part I: diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019;81(1):76–90 First North American hidradenitis suppurativa clinical management guidelines provide evidence-based recommendations for a variety of surgical interventions. •• Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part I: diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019;81(1):76–90 First North American hidradenitis suppurativa clinical management guidelines provide evidence-based recommendations for a variety of surgical interventions.
11.
Zurück zum Zitat •• Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part II: topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019;81(1):91–101 Part II of the North American clinical management guidelines includes discussion of intralesional and medical therapy. •• Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part II: topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019;81(1):91–101 Part II of the North American clinical management guidelines includes discussion of intralesional and medical therapy.
12.
Zurück zum Zitat •• Kohorst JJ, Baum CL, Otley CC, et al. Patient satisfaction and quality of life following surgery for hidradenitis suppurativa. Dermatol Surg. 2017;43(1):125–33 Large retrospective study including surveys demonstrating improved quality of life following a range of surgical approaches. PubMedCrossRef •• Kohorst JJ, Baum CL, Otley CC, et al. Patient satisfaction and quality of life following surgery for hidradenitis suppurativa. Dermatol Surg. 2017;43(1):125–33 Large retrospective study including surveys demonstrating improved quality of life following a range of surgical approaches. PubMedCrossRef
13.
Zurück zum Zitat Wollina U, Kostler E, Schonlebe J, Haroske G. Tumescent suction curettage versus minimal skin resection with subcutaneous curettage of sweat glands in axillary hyperhidrosis. Dermatol Surg. 2008;34(5):709–16.PubMed Wollina U, Kostler E, Schonlebe J, Haroske G. Tumescent suction curettage versus minimal skin resection with subcutaneous curettage of sweat glands in axillary hyperhidrosis. Dermatol Surg. 2008;34(5):709–16.PubMed
14.
Zurück zum Zitat Riis PT, Boer J, Prens EP, Saunte DML, Deckers IE, Emtestam L, et al. Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): a case series. J Am Acad Dermatol. 2016;75(6):1151–5.PubMedCrossRef Riis PT, Boer J, Prens EP, Saunte DML, Deckers IE, Emtestam L, et al. Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): a case series. J Am Acad Dermatol. 2016;75(6):1151–5.PubMedCrossRef
15.
Zurück zum Zitat Ritz JP, Runkel N, Haier J, Buhr HJ. Extent of surgery and recurrence rate of hidradenitis suppurativa. Int J Color Dis. 1998;13(4):164–8.CrossRef Ritz JP, Runkel N, Haier J, Buhr HJ. Extent of surgery and recurrence rate of hidradenitis suppurativa. Int J Color Dis. 1998;13(4):164–8.CrossRef
16.
Zurück zum Zitat van der Zee HH, Prens EP, Boer J. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol. 2010;63(3):475–80.PubMedCrossRef van der Zee HH, Prens EP, Boer J. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol. 2010;63(3):475–80.PubMedCrossRef
17.
Zurück zum Zitat van Hattem S, Spoo JR, Horvath B, Jonkman MF, Leeman FW. Surgical treatment of sinuses by deroofing in hidradenitis suppurativa. Dermatol Surg. 2012;38(3):494–7.PubMedCrossRef van Hattem S, Spoo JR, Horvath B, Jonkman MF, Leeman FW. Surgical treatment of sinuses by deroofing in hidradenitis suppurativa. Dermatol Surg. 2012;38(3):494–7.PubMedCrossRef
18.
Zurück zum Zitat van Rappard DC, Mooij JE, Mekkes JR. Mild to moderate hidradenitis suppurativa treated with local excision and primary closure. J Eur Acad Dermatol Venereol : JEADV. 2012;26(7):898–902.PubMedCrossRef van Rappard DC, Mooij JE, Mekkes JR. Mild to moderate hidradenitis suppurativa treated with local excision and primary closure. J Eur Acad Dermatol Venereol : JEADV. 2012;26(7):898–902.PubMedCrossRef
19.
Zurück zum Zitat Kofler L, Schweinzer K, Heister M, Kohler M, Breuninger H, Hafner HM. Surgical treatment of hidradenitis suppurativa: an analysis of postoperative outcome, cosmetic results and quality of life in 255 patients. J Eur Acad Dermatol Venereol : JEADV. 2018;32(9):1570–4.PubMedCrossRef Kofler L, Schweinzer K, Heister M, Kohler M, Breuninger H, Hafner HM. Surgical treatment of hidradenitis suppurativa: an analysis of postoperative outcome, cosmetic results and quality of life in 255 patients. J Eur Acad Dermatol Venereol : JEADV. 2018;32(9):1570–4.PubMedCrossRef
20.
Zurück zum Zitat Deckers IE, Dahi Y, van der Zee HH, Prens EP. Hidradenitis suppurativa treated with wide excision and second intention healing: a meaningful local cure rate after 253 procedures. J Eur Acad Dermatol Venereol : JEADV. 2018;32(3):459–62.PubMedCrossRef Deckers IE, Dahi Y, van der Zee HH, Prens EP. Hidradenitis suppurativa treated with wide excision and second intention healing: a meaningful local cure rate after 253 procedures. J Eur Acad Dermatol Venereol : JEADV. 2018;32(3):459–62.PubMedCrossRef
21.
Zurück zum Zitat DeFazio MV, Economides JM, King KS, et al. Outcomes after combined radical resection and targeted biologic therapy for the management of recalcitrant hidradenitis suppurativa. Ann Plast Surg. 2016;77(2):217–22.PubMedPubMedCentralCrossRef DeFazio MV, Economides JM, King KS, et al. Outcomes after combined radical resection and targeted biologic therapy for the management of recalcitrant hidradenitis suppurativa. Ann Plast Surg. 2016;77(2):217–22.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Shanmugam VK, Mulani S, McNish S, Harris S, Buescher T, Amdur R. Longitudinal observational study of hidradenitis suppurativa: impact of surgical intervention with adjunctive biologic therapy. Int J Dermatol. 2018;57(1):62–9.PubMedCrossRef Shanmugam VK, Mulani S, McNish S, Harris S, Buescher T, Amdur R. Longitudinal observational study of hidradenitis suppurativa: impact of surgical intervention with adjunctive biologic therapy. Int J Dermatol. 2018;57(1):62–9.PubMedCrossRef
23.
Zurück zum Zitat Wortsman X, Castro A, Figueroa A. Color Doppler ultrasound assessment of morphology and types of fistulous tracts in hidradenitis suppurativa (HS). J Am Acad Dermatol. 2016;75(4):760–7.PubMedCrossRef Wortsman X, Castro A, Figueroa A. Color Doppler ultrasound assessment of morphology and types of fistulous tracts in hidradenitis suppurativa (HS). J Am Acad Dermatol. 2016;75(4):760–7.PubMedCrossRef
24.
Zurück zum Zitat Miedema J, Sayed C. Staged excision in the outpatient setting for the treatment of axillary hidradenitis suppurativa. Dermatol Surg. 2016;42(2):267–9.PubMedCrossRef Miedema J, Sayed C. Staged excision in the outpatient setting for the treatment of axillary hidradenitis suppurativa. Dermatol Surg. 2016;42(2):267–9.PubMedCrossRef
25.
Zurück zum Zitat Kohorst JJ, Baum CL, Otley CC, et al. Surgical management of hidradenitis suppurativa: outcomes of 590 consecutive patients. Dermatol Surg. 2016;42(9):1030–40.PubMedCrossRef Kohorst JJ, Baum CL, Otley CC, et al. Surgical management of hidradenitis suppurativa: outcomes of 590 consecutive patients. Dermatol Surg. 2016;42(9):1030–40.PubMedCrossRef
26.
Zurück zum Zitat Oliveira MEF, Sayed C. Intercostobrachial neuralgia after axillary surgery for hidradenitis suppurativa. Dermatol Surg. 2018;44(11):1470–2.PubMedCrossRef Oliveira MEF, Sayed C. Intercostobrachial neuralgia after axillary surgery for hidradenitis suppurativa. Dermatol Surg. 2018;44(11):1470–2.PubMedCrossRef
27.
Zurück zum Zitat Hazen PG, Hazen BP. Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization. Dermatol Surg. 2010;36(2):208–13.PubMedCrossRef Hazen PG, Hazen BP. Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization. Dermatol Surg. 2010;36(2):208–13.PubMedCrossRef
28.
Zurück zum Zitat Mikkelsen PR, Dufour DN, Zarchi K, Jemec GB. Recurrence rate and patient satisfaction of CO2 laser evaporation of lesions in patients with hidradenitis suppurativa: a retrospective study. Dermatol Surg. 2015;41(2):255–60.PubMedCrossRef Mikkelsen PR, Dufour DN, Zarchi K, Jemec GB. Recurrence rate and patient satisfaction of CO2 laser evaporation of lesions in patients with hidradenitis suppurativa: a retrospective study. Dermatol Surg. 2015;41(2):255–60.PubMedCrossRef
29.
Zurück zum Zitat Madan V, Hindle E, Hussain W, August PJ. Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser. Br J Dermatol. 2008;159(6):1309–14.PubMedCrossRef Madan V, Hindle E, Hussain W, August PJ. Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser. Br J Dermatol. 2008;159(6):1309–14.PubMedCrossRef
30.
Zurück zum Zitat Tierney E, Mahmoud BH, Hexsel C, Ozog D, Hamzavi I. Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminium garnet laser. Dermatol Surg. 2009;35(8):1188–98.PubMedCrossRef Tierney E, Mahmoud BH, Hexsel C, Ozog D, Hamzavi I. Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminium garnet laser. Dermatol Surg. 2009;35(8):1188–98.PubMedCrossRef
31.
Zurück zum Zitat Mahmoud BH, Tierney E, Hexsel CL, Pui J, Ozog DM, Hamzavi IH. Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser. J Am Acad Dermatol. 2010;62(4):637–45.PubMedCrossRef Mahmoud BH, Tierney E, Hexsel CL, Pui J, Ozog DM, Hamzavi IH. Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser. J Am Acad Dermatol. 2010;62(4):637–45.PubMedCrossRef
32.
Zurück zum Zitat Chen YE, Gerstle T, Verma K, Treiser MD, Kimball AB, Orgill DP. Management of hidradenitis suppurativa wounds with an internal vacuum-assisted closure device. Plast Reconstr Surg. 2014;133(3):370e–7e.PubMedCrossRef Chen YE, Gerstle T, Verma K, Treiser MD, Kimball AB, Orgill DP. Management of hidradenitis suppurativa wounds with an internal vacuum-assisted closure device. Plast Reconstr Surg. 2014;133(3):370e–7e.PubMedCrossRef
33.
Zurück zum Zitat Elwood ET, Bolitho DG. Negative-pressure dressings in the treatment of hidradenitis suppurativa. Ann Plast Surg. 2001;46(1):49–51.PubMedCrossRef Elwood ET, Bolitho DG. Negative-pressure dressings in the treatment of hidradenitis suppurativa. Ann Plast Surg. 2001;46(1):49–51.PubMedCrossRef
34.
Zurück zum Zitat Ge S, Orbay H, Silverman RP, Rasko YM. Negative pressure wound therapy with instillation and dwell time in the surgical management of severe hidradenitis suppurativa. Cureus. 2018;10(9):e3319.PubMedPubMedCentral Ge S, Orbay H, Silverman RP, Rasko YM. Negative pressure wound therapy with instillation and dwell time in the surgical management of severe hidradenitis suppurativa. Cureus. 2018;10(9):e3319.PubMedPubMedCentral
35.
Zurück zum Zitat Alavi A, Sibbald RG, Kirsner RS. Optimal hidradenitis suppurativa topical treatment and wound care management: a revised algorithm. J Dermatol Treat. 2017;29(4):383–84. Alavi A, Sibbald RG, Kirsner RS. Optimal hidradenitis suppurativa topical treatment and wound care management: a revised algorithm. J Dermatol Treat. 2017;29(4):383–84.
36.
Zurück zum Zitat Humphries LS, Kueberuwa E, Beederman M, Gottlieb LJ. Wide excision and healing by secondary intent for the surgical treatment of hidradenitis suppurativa: a single-center experience. J Plast Reconstr Aesthet Surg : JPRAS. 2016;69(4):554–66.PubMedCrossRef Humphries LS, Kueberuwa E, Beederman M, Gottlieb LJ. Wide excision and healing by secondary intent for the surgical treatment of hidradenitis suppurativa: a single-center experience. J Plast Reconstr Aesthet Surg : JPRAS. 2016;69(4):554–66.PubMedCrossRef
37.
Zurück zum Zitat Kazemi A, Carnaggio K, Clark M, Shephard C, Okoye GA. Optimal wound care management in hidradenitis suppurativa. J Dermatol Treat. 2018;29(2):165–7.CrossRef Kazemi A, Carnaggio K, Clark M, Shephard C, Okoye GA. Optimal wound care management in hidradenitis suppurativa. J Dermatol Treat. 2018;29(2):165–7.CrossRef
38.
Zurück zum Zitat Pearce FB Jr, Richardson KA. Negative pressure wound therapy, staged excision and definitive closure with split-thickness skin graft for axillary hidradenitis suppurativa: a retrospective study. J Wound Care. 2017;26(Sup1):S36–42.PubMedCrossRef Pearce FB Jr, Richardson KA. Negative pressure wound therapy, staged excision and definitive closure with split-thickness skin graft for axillary hidradenitis suppurativa: a retrospective study. J Wound Care. 2017;26(Sup1):S36–42.PubMedCrossRef
39.
Zurück zum Zitat Silverberg B, Smoot CE, Landa SJ, Parsons RW. Hidradenitis suppurativa: patient satisfaction with wound healing by secondary intention. Plast Reconstr Surg. 1987;79(4):555–9.PubMedCrossRef Silverberg B, Smoot CE, Landa SJ, Parsons RW. Hidradenitis suppurativa: patient satisfaction with wound healing by secondary intention. Plast Reconstr Surg. 1987;79(4):555–9.PubMedCrossRef
40.
Zurück zum Zitat Bordier-Lamy F, Palot JP, Vitry F, Bernard P, Grange F. Surgical treatment of hidradenitis suppurativa: a retrospective study of 93 cases. Ann Dermatol Venereol 2008;135(5):373–379, Maladie de Verneuil : étude rétrospective chez 93 malades traités chirurgicalement. Bordier-Lamy F, Palot JP, Vitry F, Bernard P, Grange F. Surgical treatment of hidradenitis suppurativa: a retrospective study of 93 cases. Ann Dermatol Venereol 2008;135(5):373–379, Maladie de Verneuil : étude rétrospective chez 93 malades traités chirurgicalement.
41.
Zurück zum Zitat Burney RE. 35-year experience with surgical treatment of hidradenitis suppurativa. World J Surg. 2017;41(11):2723–30.PubMedCrossRef Burney RE. 35-year experience with surgical treatment of hidradenitis suppurativa. World J Surg. 2017;41(11):2723–30.PubMedCrossRef
42.
Zurück zum Zitat Kagan RJ, Yakuboff KP, Warner P, Warden GD. Surgical treatment of hidradenitis suppurativa: a 10-year experience. Surgery. 2005;138(4):734–40 discussion 740-731.PubMedCrossRef Kagan RJ, Yakuboff KP, Warner P, Warden GD. Surgical treatment of hidradenitis suppurativa: a 10-year experience. Surgery. 2005;138(4):734–40 discussion 740-731.PubMedCrossRef
43.
Zurück zum Zitat Mehdizadeh A, Hazen PG, Bechara FG, Zwingerman N, Moazenzadeh M, Bashash M, et al. Recurrence of hidradenitis suppurativa after surgical management: a systematic review and meta-analysis. J Am Acad Dermatol. 2015;73(5 Suppl 1):S70–7.PubMedCrossRef Mehdizadeh A, Hazen PG, Bechara FG, Zwingerman N, Moazenzadeh M, Bashash M, et al. Recurrence of hidradenitis suppurativa after surgical management: a systematic review and meta-analysis. J Am Acad Dermatol. 2015;73(5 Suppl 1):S70–7.PubMedCrossRef
44.
Zurück zum Zitat Blok JL, Boersma M, Terra JB, Spoo JR, Leeman FWJ, van den Heuvel ER, et al. Surgery under general anaesthesia in severe hidradenitis suppurativa: a study of 363 primary operations in 113 patients. J Eur Acad Dermatol Venereol: JEADV. 2015;29(8):1590–7.PubMedCrossRef Blok JL, Boersma M, Terra JB, Spoo JR, Leeman FWJ, van den Heuvel ER, et al. Surgery under general anaesthesia in severe hidradenitis suppurativa: a study of 363 primary operations in 113 patients. J Eur Acad Dermatol Venereol: JEADV. 2015;29(8):1590–7.PubMedCrossRef
Metadaten
Titel
Clinic-Based Surgical Treatment for Hidradenitis Suppurativa
verfasst von
Kristen Fajgenbaum
Jonathan Bissette
Christopher Sayed
Publikationsdatum
01.07.2019
Verlag
Springer US
Erschienen in
Current Dermatology Reports / Ausgabe 3/2019
Elektronische ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-019-00266-1

Weitere Artikel der Ausgabe 3/2019

Current Dermatology Reports 3/2019 Zur Ausgabe

Photodermatology (B Adler And V Deleo, Section Editors)

Chronic Actinic Dermatitis: a Review

Skin Cancer (E Tongdee and O Markowitz, Section Editors)

Advanced Squamous Cell Carcinoma: What’s New?

Teledermatology (D Oh, Section Editor)

Teledermatology in Underserved Populations

Photodermatology (B Adler and V DeLeo, Section Editor)

Polymorphous Light Eruption: a Review

Skin Cancer (E Tongdee and O Markowitz, Section Editors)

Artificial Intelligence in Skin Cancer

Teledermatology (D Oh, Section Editor)

Artificial Intelligence in Teledermatology

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.